��� Sonavex’s EchoMap™ is FDA Cleared 💥
We are thrilled to share that the newest Sonavex device, EchoMap, received FDA 510(k) clearance.
Read more about it here: https://t.co/dpzvqe8B5y
Sonavex is pleased to announce the publication of new data demonstrating the feasibility and accuracy of EchoMark & EchoSure for AV fistula maturation assessment in the Journal of Vascular Access. Check out the article here: https://t.co/122ZGsrOTj #EmpoweredPatientCare
We are pleased to announce that the @NIH@NIDDKgov has awarded @Sonavex a $2M grant to conduct a clinical trial and seek regulatory clearance of our pipeline product EchoGuide. Read more about it here: https://t.co/akbEBT3cb5
#NIH#NIDDK#EchoGuide#EmpoweredPatientCare
Celebrate #WorldKidneyDay with us! Today, we join in the efforts to raise awareness on the importance of your kidneys and managing kidney health. Check out this link to learn more: https://t.co/4hOJg8irbs
We are pleased to announce the successful completion of our prospective multicenter U.S. clinical study of #EchoMark & #EchoSure for AV fistula patients and IDE approval of our randomized controlled trial MAFASA https://t.co/JPrBRZ37kQ
We’re excited to have the latest data from our clinical study presented at the #VEITH2023 Conference. Alex Yevzlin, MD will share results from our prospective multicenter study of #EchoMark and #EchoSure for AV Fistula Maturation. #Sonavex#EmpoweredPatientCare#dialysis
@Sonavex has completed enrollment in our prospective multi-center U.S. IDE feasibility study for AV fistula patients. We are beyond grateful to the patients, investigators, research coordinators, and our internal team for everyone’s support and hard work. #EmpoweredPatientCare
Today is #WorldKidneyDay. Kidney disease impacts 850 million people and involves complex, ongoing treatment. At @Sonavex, we are working to improve outcomes for hemodialysis patients with our novel ultrasound technology. For more #WorldKidneyDay info visit https://t.co/EHPqCj7yU9
It's National Kidney Month! End stage kidney disease impacts 786,000 people in the US but dialysis can replace some key kidney functions. At Sonavex, we are working to improve the lives of hemodialysis patients with our automated ultrasound technology. https://t.co/d8FPtg31vY
NEW ISSUED PATENT ALERT! Sonavex was recently issued a broad U.S. patent protecting its EchoMark technology and methods associated with using EchoMark to facilitate vascular ultrasound exams
We are pleased to announce that we have been awarded a $1.7 million grant from the @NIH. This grant will fund the further development of our pipeline product, EchoGuide. Thank you to the @NIH for the ongoing support to help us improve clinical care.
https://t.co/gPwA5ltegj
Latest validation study results published in the Journal of Vascular Access demonstrate that EchoSure, when used by dialysis techs and nurses, is both accurate and precise. Follow the link here to learn more:
https://t.co/9dbfrYQZIS
#EchoMark#EchoSure#avf#dialysisaccess
2022 is off to an exciting start at Sonavex – join our CEO David Narrow at #LSIUSA22 to learn about our unique solution to some of the biggest problems in dialysis access care. @lsintelligence
Portfolio company @Sonavex appoints Alex Yevzlin as its Chief Medical Officer and forms a world class Advisory Board as it continues to build innovative ultrasound technologies!
https://t.co/oAocebtzD4
We are thrilled to announce the addition of Chief Medical Officer Dr. Alex Yevzlin to the team, along with the launch of an Advisory Board, including Dr. Randy Cooper, Terry Litchfield, and Dr. John Ross. Learn more about our newest team members at https://t.co/ZCNnYJnNO6
Presenting the #MedTechInnovator2020 Showcase - Renal Panel featuring: @cellvie2, @RelavoMedical, @SentienBiotech & @Sonavex. Watch their 1-min introductory videos below, then check out @MedTechCon for their full panel starting Fri. Sept. 18. https://t.co/kRzMDetxGW